Assessment of molecular subtypes in addition to PD-L1 expression as well as tumor mutational load, CD8+ T cells, M2 macrophages, CTL4, and TNFβ in tumor-related fibroblasts are also promising areas for future studies. This evidence concerns the gene SLC44A4 and neoplasm.